Technology | May 08, 2007

FDA Clears Computer-Controlled Surgical Ablation System

MedicalCV Inc. has received FDA clearance for its SOLAR Surgical Ablation System for the ablation of soft tissue. The company developed the SOLAR System to enable automated, computer-controlled ablation in surgical procedures utilizing laser energy.

MedicalCV Inc. is a medical device company that develops, manufactures and sells surgical ablation systems that utilize a laser energy technology platform to create precise lesions, or scars, on soft and cardiac tissues. The Company's core technologies are the SOLAR and ATRILAZE


Additional Content

News

Sept. 8, 2026 — Abbot has announced that it has received U.S. Food and Drug Administration (FDA) approval for the ...

Home September 08, 2026
Home
News

Aug. 31, 2026 — At the European Society of Cardiology Congress in Munich, Abbott announced new late-breaking 12-month ...

Home September 02, 2026
Home
News

July 8, 2026 — Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) approved the Dual Energy ...

Home July 08, 2026
Home
News

May 21, 2026 — Adagio Medical Holdings, a provider of catheter ablation technologies for treating cardiac arrhythmias ...

Home May 22, 2026
Home
News

April 26, 2026 — New results from the multicenter catheter ablation versus anti-arrhythmic drugs for Ventricular ...

Home April 29, 2026
Home
Subscribe Now